12 results
20-F
2020 FY
PRFX
PainReform Ltd
18 Mar 21
Annual report (foreign)
9:03am
inputs such as raw materials and drug products may impair our business;
We may not be able to successfully identify and execute strategic alliances … commitments imposed by FDA or other applicable regulatory authorities;
establishment of supply arrangements with third-party raw materials and drug
424B4
PRFX
PainReform Ltd
2 Sep 20
Prospectus supplement with pricing info
4:09pm
or other applicable regulatory authorities;
establishment of supply arrangements with third-party raw materials and drug product suppliers … liability claim or product recall may result in material losses.
Significant interruptions in our access to certain key inputs such as raw materials
F-1/A
PRFX
PainReform Ltd
31 Aug 20
Registration statement (foreign) (amended)
6:06am
with third-party raw materials and drug product suppliers and manufacturers who are able to manufacture clinical trial and commercial quantities of PRF-110 … in our access to certain key inputs such as raw materials and drug products may impair our business.
Our business is dependent on a number of key
F-1/A
x9tr5kjer
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
j6crzmfnc2a47k0uvec
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
F-1/A
dg2t0 rzqg
5 Aug 20
Registration statement (foreign) (amended)
1:26pm
F-1
kduxnmx0pq121
30 Jun 20
Registration statement (foreign)
5:16pm
DRS/A
69wxcyj58muxxavvfx0
2 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
bh0nh
12 May 20
Draft registration statement (amended)
12:00am
DRS
11zcbs
3 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next